Dengler R - Search Results

1

Botulinum A toxin therapy: neutralizing and nonneutralizing antibodies--therapeutic consequences.

Göschel H, Wohlfarth K, Frevert J, Dengler R, Bigalke H. Göschel H, et al. Among authors: dengler r. Exp Neurol. 1997 Sep;147(1):96-102. doi: 10.1006/exnr.1997.6580. Exp Neurol. 1997. PMID: 9294406 Clinical Trial.

2

A long-term follow-up of botulinum toxin A in cervical dystonia.

Mohammadi B, Buhr N, Bigalke H, Krampfl K, Dengler R, Kollewe K. Mohammadi B, et al. Among authors: dengler r. Neurol Res. 2009 Jun;31(5):463-6. doi: 10.1179/174313209X405137. Epub 2009 Mar 11. Neurol Res. 2009. PMID: 19278576

3

Botulinum A toxins: units versus units.

Wohlfarth K, Göschel H, Frevert J, Dengler R, Bigalke H. Wohlfarth K, et al. Among authors: dengler r. Naunyn Schmiedebergs Arch Pharmacol. 1997 Mar;355(3):335-40. doi: 10.1007/pl00004951. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9089663 Clinical Trial.

4

Low-dose treatment of cervical dystonia, blepharospasm and facial hemispasm with albumin-diluted botulinum toxin type A under EMG guidance. An open label study.

Rollnik JD, Matzke M, Wohlfarth K, Dengler R, Bigalke H. Rollnik JD, et al. Among authors: dengler r. Eur Neurol. 2000;43(1):9-12. doi: 10.1159/000008121. Eur Neurol. 2000. PMID: 10601802 Clinical Trial.

5

Botulinum toxin treatment of cocontractions after birth-related brachial plexus lesions.

Rollnik JD, Hierner R, Schubert M, Shen ZL, Johannes S, Tröger M, Wohlfarth K, Berger AC, Dengler R. Rollnik JD, et al. Among authors: dengler r. Neurology. 2000 Jul 12;55(1):112-4. doi: 10.1212/wnl.55.1.112. Neurology. 2000. PMID: 10891916 Clinical Trial.

6

Botulinum A toxin: Dysport improvement of biological availability.

Bigalke H, Wohlfarth K, Irmer A, Dengler R. Bigalke H, et al. Among authors: dengler r. Exp Neurol. 2001 Mar;168(1):162-70. doi: 10.1006/exnr.2000.7583. Exp Neurol. 2001. PMID: 11170731 Clinical Trial.

7

Neutralizing botulinum toxin type a antibodies: clinical observations in patients with cervical dystonia.

Rollnik JD, Wohlfarth K, Dengler R, Bigalke H. Rollnik JD, et al. Among authors: dengler r. Neurol Clin Neurophysiol. 2001;2001(3):2-4. doi: 10.1162/152687401300343571. Neurol Clin Neurophysiol. 2001. PMID: 12396862 Clinical Trial.

8

Local botulinum toxin in the treatment of spastic drop foot.

Dengler R, Neyer U, Wohlfarth K, Bettig U, Janzik HH. Dengler R, et al. J Neurol. 1992 Aug;239(7):375-8. doi: 10.1007/BF00812153. J Neurol. 1992. PMID: 1403018

9

Supraglottal injection of botulinum toxin type A in adductor type spasmodic dysphonia with both intrinsic and extrinsic hyperfunction.

Schönweiler R, Wohlfarth K, Dengler R, Ptok M. Schönweiler R, et al. Among authors: dengler r. Laryngoscope. 1998 Jan;108(1 Pt 1):55-63. doi: 10.1097/00005537-199801000-00011. Laryngoscope. 1998. PMID: 9432068

10

Remote F-wave changes after local botulinum toxin application.

Wohlfarth K, Schubert M, Rothe B, Elek J, Dengler R. Wohlfarth K, et al. Among authors: dengler r. Clin Neurophysiol. 2001 Apr;112(4):636-40. doi: 10.1016/s1388-2457(01)00478-3. Clin Neurophysiol. 2001. PMID: 11275536

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

460 results

Search Page